Collectively, the biodynamers offer insight into a potential strategy to further enhance the selectivity of cell-penetrating agents for drug delivery in acidic disease microenvironments.
Abstract
Target-specific strategies are essential for the success of modern drug therapy in terms of safety and effectiveness. Thus, drug delivery must extend beyond tissue-level targeting to intracellular targeting, which is the ultimate site of action. Cell-penetrating peptides (CPPs) have therefore emerged as an approach to deliver drugs into target cells, yet concerns remain regarding cytotoxicity and limited targeting precision. In this context, we investigated biodynamers as a new class of pH-responsive CPPs. Biodynamers are dynamic peptide analogs, composed of amino acid-hydrazides together with a hexaethylene glycol-conjugated carbazole dialdehyde monomer. Each monomer is linked through pH-sensitive dynamic covalent bonds. Therefore, under acidic conditions, these polymers undergo structural rearrangements, including changes in molecular weight and conformation, potentially influencing their pH-dependent uptake. We synthesized three biodynamers with varying Lys-to-Arg ratios and evaluated their uptake in A549 and SW480 cells by pH. All biodynamers exhibited significantly higher uptake in acidic media (pH 6.0, HBSS) compared to neutral conditions at pH 7.4. This acid-induced uptake appears to be promoted by the enhanced electrostatic interactions between the biodynamers and the cell membrane, driven by dynamic degradation of the biodynamer under acidic conditions. Such degradation increases the number of terminal amino groups, thereby elevating charge density. Furthermore, circular dichroism results indicate a conformational change is induced under acidic conditions, which likely contributes to the enhanced cellular internalization as seen with conventional CPPs. Collectively, the biodynamers offer insight into a potential strategy to further enhance the selectivity of cell-penetrating agents for drug delivery in acidic disease microenvironments.
The importance of formulation optimization in improving nucleic acid delivery is highlighted and practical insights for enhancing peptide- and lipid-based therapeutic platforms are provided.
D. Daniele, Z. Hein, O. Saher et al.· International Journal of Pha...· 0 citations
The intracellular delivery of therapeutic biomacromolecules remains a fundamental challenge in modern drug development, primarily because the plasma membrane is inherently impermeable to large, hydrophilic molecules. While conventional small-molecule drugs also suffer from short circulation half-lives and off-target in...
P. Kavyashree, Rachel Anjous, K. Parang et al.· European journal of medicina...· 0 citations
The rational design of a pH-tunable DNA tetrahedron (pHTd) is reported through the strategic incorporation of an i-motif, enabling assembly at physiological pH and disassembly under acidic conditions, thereby exhibiting reversible structural transitions in response to pH changes.
Peptides have emerged as promising anticancer agents due to their biocompatibility and functional versatility, such as tumor targeting and cell penetrating capabilities. However, their clinical application is often limited by poor stability and rapid clearance. To overcome these drawbacks, peptide assembly strategies h...
Guo-Wei Liang, Xian-Bao Sun, Yu Ma et al.· Angewandte Chemie· 0 citations
Cancer remains a major global health challenge, and nanoparticle-based drug delivery systems have emerged as a promising strategy for targeted cancer therapy. However, clinical translation is still limited by an incomplete understanding of how nanoparticles navigate the tumor microenvironment (TME) throughout the deliv...
Meng-Xin Ban, Si-Fang Zhao, Zi-Yu Liu et al.· Pharmaceutics· 0 citations
Conventional cancer therapies are often limited by inadequate drug accumulation in tumors, drug resistance, and systemic toxicity. Cell-penetrating peptides (CPPs) offer a promising strategy to enhance intracellular drug delivery. In this study, we designed a novel tumor-penetrating peptide, P3 (sequence: Trp-Lys-Ala-S...
Yi-Chen Tian, Ya-Nan Li, Meng-Yu Cao et al.· Small· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.